UPDATE: Nemus Bioscience, Inc. Signs Agreement with Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredient for Glaucoma
August 01, 2018 09:54 ET
|
Nemus Bioscience, Inc.
Long Beach, CA, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially...
Albany Molecular Research Inc. (AMRI) Selects FirstLight Fiber for 10 Gbps Network Upgrade
February 27, 2014 08:05 ET
|
FirstLight Fiber
ALBANY, NY--(Marketwired - Feb 27, 2014) - FirstLight Fiber, a facilities-based telecommunications service provider operating fiber optic networks in Upstate New York and Northern New England...